New combo pill for high cholesterol tested in nearly 2,000 patients
NCT ID NCT05559606
First seen Oct 31, 2025 · Last updated May 17, 2026 · Updated 29 times
Summary
This study looked at 1,839 adults with high cholesterol who were given a combination pill containing atorvastatin and ezetimibe for 24 weeks. Researchers wanted to see how well the pill lowered bad cholesterol and if it was safe in everyday medical practice. The goal was to understand how this fixed-dose therapy works outside of strict clinical trial settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.